Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Lung Cancer

  Free Subscription


19.03.2018

1 Ann Oncol
3 Ann Thorac Surg
3 Anticancer Res
1 Arch Bronconeumol
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
1 Cancer Sci
1 Clin Cancer Res
3 Clin Lung Cancer
1 J Clin Oncol
1 J Natl Cancer Inst
2 J Thorac Cardiovasc Surg
7 J Thorac Oncol
1 Oncologist
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. MCCOACH CE, Blumenthal GM, Zhang L, Myers A, et al
    Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy.
    Ann Oncol. 2018 Feb 26. pii: 4909805. doi: 10.1093.
    PubMed     Text format    


    Ann Thorac Surg

  2. NELSON DB, Godoy MC, Benveniste MF, Shewale JB, et al
    Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer with Ground Glass Components.
    Ann Thorac Surg. 2018 Mar 10. pii: S0003-4975(18)30332.
    PubMed     Text format     Abstract available

  3. RAY MA, Faris NR, Smeltzer MP, Fehnel C, et al
    Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2018 Mar 10. pii: S0003-4975(18)30333.
    PubMed     Text format     Abstract available

  4. VAN HAREN RM, Mehran RJ, Correa AM, Antonoff MB, et al
    Enhanced Recovery Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Lung Cancer.
    Ann Thorac Surg. 2018 Mar 9. pii: S0003-4975(18)30318.
    PubMed     Text format     Abstract available


    Anticancer Res

  5. NASU S, Suzuki H, Shiroyama T, Tanaka A, et al
    Skin Rash Can Be a Useful Marker for Afatinib Efficacy.
    Anticancer Res. 2018;38:1783-1788.
    PubMed     Text format     Abstract available

  6. MATSUBARA T, Toyokawa G, Kinoshita F, Haratake N, et al
    Safety of Simultaneous Bilateral Pulmonary Resection for Metastatic Lung Tumors.
    Anticancer Res. 2018;38:1715-1719.
    PubMed     Text format     Abstract available

  7. SATO Y, Fujimoto D, Uehara K, Kawachi H, et al
    Reduced Tumour Proportion Scores for Programmed Cell Death Ligand 1 in Stored Paraffin Tissue Sections.
    Anticancer Res. 2018;38:1401-1405.
    PubMed     Text format     Abstract available


    Arch Bronconeumol

  8. CEREZO LAJAS A, Alijo Serrano F, Rodriguez de Guzman MDC, de Miguel Diez J, et al
    Primary Pleural Synovial Sarcoma: Differential Diagnosis with Small Cell Lung Carcinoma.
    Arch Bronconeumol. 2018 Mar 9. pii: S0300-2896(18)30025.
    PubMed     Text format    


    Cancer Epidemiol Biomarkers Prev

  9. LIN J, Kamamia C, Brown D, Shao S, et al
    Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER population.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 12. pii: 1055-9965.EPI-17-0822.
    PubMed     Text format     Abstract available


    Cancer Lett

  10. CAO X, Zhou Y, Sun H, Xu M, et al
    EGFR-TKI-induced HSP70 degradation and BER suppression facilitate the occurrence of the EGFR T790M resistant mutation in lung cancer cells.
    Cancer Lett. 2018 Mar 7. pii: S0304-3835(18)30193.
    PubMed     Text format     Abstract available


    Cancer Sci

  11. TORIGOE H, Shien K, Takeda T, Yoshioka T, et al
    Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.
    Cancer Sci. 2018 Mar 13. doi: 10.1111/cas.13571.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  12. CASTELLANOS-RIZALDOS E, Grimm DG, Tadigotla V, Hurley J, et al
    Exosome-based Detection of EGFR T790M in Plasma from Non-Small Cell Lung Cancer Patients.
    Clin Cancer Res. 2018 Mar 13. pii: 1078-0432.CCR-17-3369.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  13. HIDA T, Kaji R, Satouchi M, Ikeda N, et al
    Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.
    Clin Lung Cancer. 2018 Feb 1. pii: S1525-7304(18)30016.
    PubMed     Text format     Abstract available

  14. WAQAR SN, Samson PP, Robinson CG, Bradley J, et al
    Non-small-cell Lung Cancer With Brain Metastasis at Presentation.
    Clin Lung Cancer. 2018 Mar 8. pii: S1525-7304(18)30019.
    PubMed     Text format     Abstract available

  15. PETRELLI F, Maltese M, Tomasello G, Conti B, et al
    Clinical and Molecular Predictors of PD-L1 Expression in Non-Small-Cell Lung Cancer: Systematic Review and Meta-analysis.
    Clin Lung Cancer. 2018 Feb 21. pii: S1525-7304(18)30025.
    PubMed     Text format     Abstract available


    J Clin Oncol

  16. LU S, Chang J, Liu X, Shi J, et al
    Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer.
    J Clin Oncol. 2018 Mar 12:JCO2017767145. doi: 10.1200/JCO.2017.76.7145.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  17. CEDRES S, Felip E, Cruz C, Martinez de Castro A, et al
    Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation.
    J Natl Cancer Inst. 2018 Feb 26. pii: 4911464. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  18. THORNBLADE LW, Wood DE, Mulligan MS, Farivar AS, et al
    Variability in invasive mediastinal staging for lung cancer: A multicenter regional study.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30311.
    PubMed     Text format     Abstract available

  19. MUNOZ-LARGACHA JA, Steiling KA, Kathuria H, Charlot M, et al
    Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30308.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  20. VERRI C, Borzi C, Holscher T, Dugo M, et al
    Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.
    J Thorac Oncol. 2017;12:922-931.
    PubMed     Text format     Abstract available

  21. SCHROCK AB, Li SD, Frampton GM, Suh J, et al
    Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
    J Thorac Oncol. 2017;12:932-942.
    PubMed     Text format     Abstract available

  22. SHAIKH F, Zauderer MG, von Reibnitz D, Wu AJ, et al
    Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
    J Thorac Oncol. 2017;12:993-1000.
    PubMed     Text format     Abstract available

  23. FARUKI H, Mayhew GM, Serody JS, Hayes DN, et al
    Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
    J Thorac Oncol. 2017;12:943-953.
    PubMed     Text format     Abstract available

  24. ROCCO G, Pennazza G, Santonico M, Longo F, et al
    Breathprinting and early diagnosis of lung cancer.
    J Thorac Oncol. 2018 Mar 8. pii: S1556-0864(18)30183.
    PubMed     Text format     Abstract available

  25. PARRA ER, Villalobos P, Zhang J, Behrens C, et al
    Immunohistochemical and Image Analysis-based Study Demonstrate that Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.
    J Thorac Oncol. 2018 Mar 8. pii: S1556-0864(18)30182.
    PubMed     Text format     Abstract available

  26. MAENG CH, Song JU, Shim SR, Lee J, et al
    The Role of Prophylactic Cranial Irradiation in Patients with Extensive Stage Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    J Thorac Oncol. 2018 Mar 8. pii: S1556-0864(18)30180.
    PubMed     Text format     Abstract available


    Oncologist

  27. SUH JH, Schrock AB, Johnson A, Lipson D, et al
    Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing.
    Oncologist. 2018 Mar 14. pii: theoncologist.2017-0493.
    PubMed     Text format     Abstract available


    PLoS One

  28. ZHANG Z, Wang H, Ding Q, Xing Y, et al
    Establishment of patient-derived tumor spheroids for non-small cell lung cancer.
    PLoS One. 2018;13:e0194016.
    PubMed     Text format     Abstract available

  29. MIHOUB M, Pichette A, Sylla B, Gauthier C, et al
    Bidesmosidic betulin saponin bearing L-rhamnopyranoside moieties induces apoptosis and inhibition of lung cancer cells growth in vitro and in vivo.
    PLoS One. 2018;13:e0193386.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: